共 50 条
- [41] Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiformeJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Vredenburgh, James J.Desjardins, AnnickPeters, Katherine B.Reardon, David A.Herndon, James EmmettCoan, April D.Kirkpatrick, JohnBailey, LeighannThreatt, StevieSampson, John HowardFriedman, Allan H.Friedman, Henry S.
- [42] Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Vredenburgh, J. J.Desjardins, A.Reardon, D. A.Peters, K.Kirkpatrick, J.Coan, A. D.Bailey, L.Janney, D.Lu, C.Friedman, H. S.
- [43] The addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly diagnosed glioblastoma multiforme (GBM).JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Friedman, Henry S.Desjardins, AnnickPeters, Katherine B.Reardon, David A.Kirkpatrick, JohnHerndon, James EmmettCoan, April D.Bailey, LeighannSampson, John HowardFriedman, Allan H.Vredenburgh, James J.
- [44] RADIOTHERAPY AND ADJUVANT TEMOZOLOMIDE COMPARED WITH RADIOTHERAPY AND CONCOMITANT PLUS ADJUVANT TEMOZOLOMIDE IN SURGICALLY TREATED PATIENTS WITH GLIOBLASTOMA MULTIFORME: A RETROSPECTIVE SINGLE INSTITUTION STUDYNEURO-ONCOLOGY, 2008, 10 (06) : 1124 - 1124Goeppert, M.Felsberg, J.Stummer, W.Reifenberger, G.Steiger, H.Sabel, M.
- [45] Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed GlioblastomaJOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2712 - 2718Stupp, RogerHegi, Monika E.Neyns, BartGoldbrunner, RolandSchlegel, UweClement, Paul M. J.Grabenbauer, Gerhard G.Ochsenbein, Adrian F.Simon, MatthiasDietrich, Pierre-YvesPietsch, TorstenHicking, ChristineTonn, Joerg-ChristianDiserens, Annie-ClairePica, AlessiaHermisson, MirjamKrueger, StefanPicard, MartinWeller, Michael
- [46] Benefit and outcome of using temozolomide-based chemoradiotherapy followed by temozolomide alone for glioblastoma in clinical practiceJOURNAL OF BUON, 2017, 22 (05): : 1233 - 1239Salma, SvetlanaDjan, IgorBjelan, MladenVulekovic, PetarNovakovic, MicoVidovic, VladimirLucic, Milos
- [47] Cabazitaxel: A new option in patients with temozolomide refractory glioblastoma multiforme?ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 119 - 120Heinrich, B.Schlenk, R. F.Brudler, O.Edenhofer, S.Thal, D. R.Mayer-Steinacker, R.Bangerter, M.Bullinger, L.
- [48] Immune modulation by combined radiation and temozolomide in glioblastoma multiforme patientsNEURO-ONCOLOGY, 2007, 9 (04) : 507 - 507Fadul, CamiloFisher, JanDemidenko, EugeneTurk, Mary JoUsherwood, EdwardErnstoff, Marc
- [49] Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and TemozolomideAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 284 - 289Topkan, ErkanTopuk, SavasOymak, EzgiParlak, CemPehlivan, Berrin
- [50] Absolute Lymphocyte Count in Patients with Glioblastoma Treated with Temozolomide ChemoradiationNEUROLOGY, 2019, 92 (15)Bamashmos, Anas Ahmed Moahmmed SaeedAli, AssadBarnett, AddisonSagar, SoumyaKnusel, KonradAhluwalia, Manmeet